News
2h
Zacks Investment Research on MSNBAYRY Skyrockets 62.9% YTD: Should You Buy or Sell the Stock?The going has been good for the German pharmaceutical giant Bayer BAYRY this year. Shares have surged 62.9% year to date ...
3h
Smithsonian Magazine on MSNHow Cancer Research for Dogs Is Helping Improve Treatment for Pets and Humans AlikeAfter a train carrying chemicals derailed and caught fire in East Palestine, Ohio, in 2023, residents were exposed to ...
Fred Hutch Cancer Center is leading the newly launched Vanguard Study, a national study of a new type of blood test that screens for several different cancers called multi-cancer detection (MCD) tests ...
A large Department of Veterans Affairs cohort study revealed key racial differences in genomic alterations among men with metastatic prostate cancer.
Prostate cancer is the most common cancer in Australia, with about 26,000 men diagnosed per year. The majority (more than 85% ...
A national pilot study designed to determine if blood tests can help detect cancers earlier is open for enrollment.Results of ...
Fred Hutch Cancer Center is leading the newly launched Vanguard Study, a national study of a new type of blood test that screens for several different cancers called multi-cancer detection (MCD) tests ...
A clinical trial is launching to test the effectiveness of new tests that aim to detect genetic signatures of cancer in the ...
A Flinders University study shows that bowel cancer survivors face an elevated risk of developing multiple primary cancers ...
The broadcaster, 67, announced his diagnosis with stage four prostate cancer in June, saying he was ‘responding positively’ to treatment.
A new research paper was published in Volume 16 of Oncotarget on June 25, 2025, titled "Hypoxia induced lipid droplet ...
Dr. Nicholas James shares why it’s important to identify which patients with high-risk, non-metastatic prostate cancer will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results